Other substances

EGYVIR

A natural extract formulation.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Natural product

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

EGYVIR is a combination of black pepper extract with curcumin extract (Roshdy et al., 2020).

 

Supporting references

Link Tested on Impact factor Notes Publication date
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
In vitro Mixed substance 		in silico; Huh-7 cells; Vero E6 cells; SARS-COV-2 strain hCoV-19/Egypt/NRC-03/2020 2.74

EGYVIR treatment inhibits the nuclear translocation of of NF-kβ p50 and pro-inflammatory signalling and has virucidal effect on SARS-CoV-2 at sub-cytotoxic levels in vitro.

 Nov/18/2020
Export (.csv)